Investment
Features
FeesSafety
Academy
More
Pluang+

Caris Life Sciences to present AI-driven cancer research at ESMO 2026, advancing precision oncology.

Market News
14 Oct 2026
PRNewsWire
View Source
Bullish
Caris Life Sciences to present AI-driven cancer research at ESMO 2026, advancing precision oncology.

Caris Life Sciences and its Precision Oncology Alliance will present eight posters at the ESMO Congress 2026 in Madrid, showcasing AI-driven approaches in cancer treatment prediction, risk stratification, and biomarker discovery. The research covers multiple cancer types including breast, lung, endometrial, and melanoma, highlighting how AI and molecular profiling improve personalized treatment strategies. This presentation underscores the growing role of AI and comprehensive data integration in precision medicine, aiming to enhance patient outcomes through tailored therapies.

Caris Life Sciences' upcoming ESMO 2026 presentations provide context for readers interested in health-sector trends. As of Oct 14, 2026 19:01 WIB, out of 150 priced Health-sector US stocks tradable on Pluang, 105 rose and 40 fell. Notable movers include BioNano Genomics Inc (BNGO) at USD 1.39 with a 1-day change of +1.84%, AstraZeneca plc (AZN) at USD 158.67 with +1.83%, and Novartis AG (NVS) at USD 144.94 with +1.78%.

More News

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...

Others
Bullish
1 hour ago
nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...

Market News
Bullish
1 hour ago
ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...

Company Fundamentals
Bullish
2 hours ago
Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...

Company Fundamentals
Bullish
2 hours ago
TSOs prioritize software investments to boost grid security and capacity amid rising demand

TSOs prioritize software investments to boost grid security and capacity amid rising demand

Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App